Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Luminex Corp Receives U.S. FDA Clearance For MAGPIX Instrument With xTAG Gastrointestinal Pathogen Panel


Monday, 15 Apr 2013 08:30am EDT 

Luminex Corp announced that it has received U.S. FDA clearance of MAGPIX instrument, with xTAG Gastrointestinal Pathogen Panel (xTAG GPP). Based on Luminex's xMAP Technology, the easy-to-use MAGPIX instrument is a versatile multiplexing platform capable of performing qualitative and quantitative analysis of proteins and nucleic acids in a variety of sample matrices. 

Company Quote

18.46
0.09 +0.49%
19 Dec 2014